Revolution Medicines Officer & Director Mark A Goldsmith Files Form 144 for $2.77M Stock Sale
Revolution Medicines, Inc.
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Notice of Proposed Sale of Securities Issuer: Revolution Medicines, Inc. ($RVMD) Insider: Mark A Goldsmith (Officer & Director) Shares to Sell: 13,603 Common Shares Aggregate Market Value: $2,771,883.31 (~$203.77/share) Approx. Sale Date: September 15, 2026 Broker: ETRADE Financial Corporation Trading Plan: Rule 10b5-1 adopted on May 31, 2023
Comprehensive Analysis
Form 144 Overview: Revolution Medicines, Inc. ($RVMD)
Insider: Mark A Goldsmith
Title/Relationship: Officer and Director
Filing Date: September 15, 2026
Transaction Summary
- Securities Offered: 13,603 shares of Common Stock
- Aggregate Market Value: $2,771,883.31 (Implied ~$203.77 per share)
- Securities Acquired Via: RSU vesting on September 15, 2026 (Services rendered)
- Broker: ETRADE Financial Corporation
- Pre-arranged Trading Plan: Executed under a Rule 10b5-1 plan adopted on May 31, 2023
Recent 3-Month Sales History
- August 21, 2026:
- Mark A Goldsmith: 80,000 shares for $16,735,887.50
- Jonathan Goldsmith Revocable Trust: 3,000 shares for $627,626.10
- Rebecca Goldsmith Revocable Trust: 3,000 shares for $627,593.26
- June 16, 2026:
- Mark A Goldsmith: 10,020 shares for $1,564,310.38
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.